IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 8 Apr · 11:55 IST

IPCA Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹1442.00
prior close
₹1434.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+0.4+0.4+0.3+0.6+0.9+1.2+2.1+1.8+1.9+5.9+7.7+14.1+22.3
Up moveDown movePending
AI summary

IPCA Laboratories has submitted a routine compliance certificate to the stock exchanges for the fourth quarter of FY26 (January–March 2026). The certificate was issued by its Registrar and Share Transfer Agent, MUFG Intime India Pvt. Ltd. (formerly Link Intime). It confirms that physical share certificates received from shareholders for dematerialisation during the quarter were properly verified, accepted or rejected, and listed on the stock exchanges. The original physical certificates were mutilated and cancelled, and the depositories' names were recorded as the registered owners in the company's member register within the prescribed timelines.

Likely market impact

This is a standard quarterly regulatory compliance filing with no material business or financial impact on shareholders. It simply confirms that share dematerialisation processes were handled correctly during Q4 FY26.